GPR30, but not estrogen receptor-α, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol

BACKGROUND: Remission of multiple sclerosis during periods of high ovarian hormone secretion (such as pregnancy) has led to a great deal of interest in the potential for estrogens to treat autoimmune disease. Previous work has established that 17β-estradiol can inhibit onset of experimental autoimmu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yates, Melissa A, Li, Yuexin, Chlebeck, Peter J, Offner, Halina
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864220/
https://www.ncbi.nlm.nih.gov/pubmed/20403194
http://dx.doi.org/10.1186/1471-2172-11-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864220/
https://www.ncbi.nlm.nih.gov/pubmed/20403194
http://dx.doi.org/10.1186/1471-2172-11-20

Ejemplares similares